We examined the effect of lactational exposure to tributyltin on innate immunodefenses in the F1 generation using in vivo and in vitro experiments. Pregnant C57BL/6 mice were given drinking water containing 0, 15, or 50 g/ml of tributyltin chloride (TBTCl) from parturition to weaning. At weaning time, offspring were inoculated with Escherichia coli K-12, and bacterial clearances from the peritoneal cavity and spleen were examined. In vivo infection experiments indicated that bacterial clearance was significantly depressed in offspring breast-fed by dams exposed to 15 g/ml of TBTCl (15 ppm F1), but not in offspring by dams exposed to 50 g/ml of TBTCl (50 ppm F1). In vitro functional assays revealed that the killing activity of neutrophils decreased significantly in 15 ppm F1, but not in 50 ppm F1. We suggest that lactational exposure to TBT impairs innate immunodefenses in the F1 generation against non-pathogenic bacterial infection.
The toxicity of organotin compounds is of special concern owing to pollution by chemicals in the form of plastic stabilizers, catalytic agents, industrial and agricultural biocides, anti-fouling paints, and pesticides. 1, 2) Due to the toxicity of tributyltin (TBT) in aquatic organisms, many countries have restricted the use of organotin compounds in anti-fouling paint.
3) But high concentrations of these compounds are still detected in the sea water and the sediment of coastal areas. 4, 5) Among organotin compounds, TBT has become a serious factor in environmental pollution, 6) and is suspected of having immunotoxic effects on animals. [7] [8] [9] [10] [11] [12] Through food chain, there is also a risk to humans who are inadvertently exposed to TBT which has accumulated in edible fish or shellfish. 12, 13) The most obvious harmful effect of TBT is immunological impairment. 14) Several immunotoxic effects, such as thymus atrophy, depletion of lymphocytes in spleen and lymph nodes, lymphopenia, alteration of serum immunoglobulin levels, and depression of host resistance to pathogenic bacteria, have been observed in laboratory animals administered high doses, more than 5 mg/kg of TBT. 13, [15] [16] [17] Among laboratory animals, rats have been reported to be susceptible to the immunotoxic activity of organotin. 3, 6) In addition, it has been reported that the immunotoxic susceptibility of TBT was higher in pre-weanling rats (3-24 d old) than in mature rats. 18) Recently, Tryphonas et al. 19) and Cooke et al. 20) investigated the effects of TBT (0.025, 0.25, and 2.5 mg/kg bw/day) on the growth, organ weights (especially of the liver), clinical chemistry, and immune system in F1 rats following in utero and post-natal exposure. They found adverse effects of TBT in offspring, such as decreases in body weights, liver weights, and the average slopes of growth profiles, when a dam was exposed to TBT at 0.025 mg/kg bw/day. These reports suggest a need to reconsider the risks associated with exposure to low doses of TBT in F1 generations. In terms of studies on the toxicity of TBT in the F1 generation, there have been a few reports about maternal exposure to TBT, 21, 22) but there is no report about immunotoxicity in offspring focusing on lactational exposure, especially as to the effects on host resistance to bacteria.
In this study, to investigate the effects of TBT on host resistance in the F1 generation, we examined parameters of innate immune responses, such as bacterial clearance activity, and functions of neutrophils and macrophages against invading bacteria, in offspring exposed to TBT via lactation.
Materials and Methods
Materials. Tributyltin chloride (TBTCl), casein, proteose peptone, gentamicin, corn oil, and Triton X-100 were purchased from Wako Pure Chemical Industries (Osaka, Japan). Luria-Bertani (LB) broth and TrypticaseÔ Soy Agar (TSA) were obtained from Becton Dickinson and Company (Sparks, MD). RPMI 1640 medium was purchased from, Sigma-Aldrich (St. Louis, MO).
Animals and chemical-exposure regimen. Pregnant C57BL/6 mice (Japan SLC, Shizuoka, Japan) were divided into three groups (four/group) and given free access to standard mouse chow and tap water. On the day dams gave birth, the litters were adjusted to eight offspring (four males and four females)/dam/cage in each group, and the dams were given water containing TBTCl (0, 15, or 50 mg/ml) ad libitum for 17 d. All drinking water had 5% sucrose. The offspring breast-fed by dams exposed to 0, 15, and 50 mg/ml of TBTCl were termed Control F1, 15 ppm F1 and 50 ppm F1, respectively. At 21 d after birth, the offspring were used for the subsequent experiments. The animal experiments in this study were performed adhering to the Principle Law on Animal Experimentation of the National Institute of Health Sciences of Japan.
Assay of bacterial clearance. Escherichia coli K-12 (E. coli K-12), DH5, were pre-cultured in LB medium overnight and part of the population was diluted, cultured again in LB medium, and harvested at a midlogarithmic phase. The bacteria [1 Â 10 8 colony forming units (CFU)/mouse] were intraperitonealy (i.p.) administered to the offspring. For assay of bacterial clearance in the spleen, the spleen was removed at 24 and 48 h after infection. To kill bacteria nonspecifically adhered to the surface of the spleen, the tissue was placed in phosphate-buffered saline (PBS) containing 100 mg/ml of gentamicin for 1 h before being washed three times with PBS. After that, the spleen was homogenized with 1 ml of 0.1% Tween/PBS. The homogenized spleen was diluted with PBS and the diluents were plated on TSA. The number of E. coli K-12 in the spleen was counted after incubation at 37 C overnight. For assay of bacterial clearance in the peritoneal cavity, at 6, 24, and 48 h after infection with E. coli K-12 (1 Â 10 8 CFU/ mouse), the peritoneal cavity was washed with 5 ml of PBS and the rinse fluid was collected. After dilution of the fluid with PBS, the E. coli K-12 in the peritoneal cavity fluid were enumerated as above.
In vitro functional assays of neutrophils or macrophages. To obtain peritoneal exudates of neutrophils or macrophages, the offspring were i.p. injected with 2 ml of 0.1% casein before 18 h to obtain neutrophils, and with 2 ml of 10% proteose peptone before 42 h to obtain macrophages. After that, the cells in the peritoneal cavity fluid were collected by centrifugation (800 rpm, 5 min). Neutrophils were obtained by collection of nonadherent cells in RPMI 1640 medium containing 10% fetal calf serum (FCS). Macrophages were obtained by removing non-adherent cells. For functional assays with the neutrophils, the cells were resuspended in RPMI 1640 medium containing 10% FCS, and placed into Eppendorf centrifuge tubes at a concentration of 5 Â 10 5 cells/200 ml. For functional assays with the macrophages, the cells were resuspended in RPMI 1640 medium containing 10% FCS, and placed into 24-well plates at a density of 5 Â 10 5 cells/500 ml. i) Binding assay: The neutrophils or macrophages were infected with 5 Â 10 7 CFU of E. coli K-12 and incubated for 1 h at 4 C. After incubation, unbound bacteria were removed by thorough washing. Each of the cells was lysed with 0.1% Triton X-100, and the lysates were diluted with PBS. The diluents were plated on TSA, and the agar plates were incubated at 37 C overnight before enumeration of E. coli K-12 bound to the cells.
ii) Phagocytotic assay and killing assay: After infection using the method described above in the section on the binding assay, the neutrophils or macrophages were incubated at 37 C for 20 min and at 37 C for 30 min respectively to phagocytize the bound bacteria. The cells were washed with PBS and incubated at 4 C for 60 min in RPMI 1640 medium containing 10% FCS and 100 mg/ml of gentamicin to remove the bacteria that were not phagocytized. After that, the cells were washed and lysed with 0.1% Triton X-100. The phagocytized bacteria were enumerated using TSA plates. Phagocytotic activity was calculated as follows: phagocytotic activity = (CFU of phagocytized bacteria/ CFU of bound bacteria) Â 100. For the killing assay, after phagocytosis of the bacteria using the method described above, neutrophils were incubated in RPMI 1640 medium containing 10% FCS and 100 mg/ml of gentamicin at 37 C for 20 min or 60 min, and macrophages were incubated for 60 min. At each time point, the cells were washed and lysed to enumerate the viable bacteria in the cells. The bacterial numbers in the cell lysates were measured with TSA plates. Killing activity was calculated as follows: killing activity = [1 À (CFU of viable bacteria in the cells at each time point/CFU of phagocytized bacteria)] Â 100.
Assay of chemokine and cytokine production in culture supernatants of neutrophils or macrophages. Neutrophils (5 Â 10 5 cells/200 ml) or macrophages (5 Â 10 5 cells/500 ml) prepared as described above were infected with 5 Â 10 7 CFU of E. coli K-12 before incubation for 1 h and subsequent washing with PBS. These cells were additionally incubated in fresh RPMI 1640 medium containing 10% FCS for 5 h and then centrifuged at 12,000 rpm for 5 min to collect culture supernatants. The supernatants were kept at À80 C prior to use. Monocyte-chemotactic protein (MCP-1) concentration in the supernatant of the cultured neutrophils and interleukin-6 (IL-6), tumor necrosis factor-(TNF-), and interleukin-1 (IL-1) concentrations in the supernatant of the cultured macrophages were determined with the corresponding cytokine assay kits (OptEIA Mouse, Pharmingen, San Diego, CA).
Confirmation of TBT transfer via breast milk. TBTCl (1,000 mg/head or 3,000 mg/head) dissolved in corn oil was p.o. administered once to 2 or 4 dams, respectively, at day 13 postpartum. The breast milk was collected from the stomach contents in F1 at 24 h after administration, which is the time TBT reached a peak in the blood. 23 ) Beforehand, at 22 h after administration, offspring were separated from dams to allow breast milk to accumulate in the mammary glands. The stomach contents of F1 were collected 1 h after allowing the offspring to suckle, and pooled depending on the administration group. Each sample (5 g) was analyzed by gas chromatography equipped with a flame photometric detector (FPD, Hewlett-Packard, Avondale, PA). The detection limit for TBT in this experiment was 50 ng/ml.
Statistical test. Data were expressed as the mean AE S.D. For comparisons of the three groups, data was analyzed by one-way of analysis of variance (ANOVA) followed by Fisher's PLSD test.
Results
Effect of lactational exposure to TBT on the body weight of offspring Table 1 shows the change in the body weight of dams and offspring exposed to TBT via lactation. Although there was no difference in body weight between the control dams and the TBT-treated dams, exposure through breast milk significantly decreased the weight of the offspring in a dose-dependent manner. These results show that doses at which there was no effect on the body weight of dams affected that of their offspring.
Elimination of E. coli K-12 from the peritoneal cavity and spleen of offspring Bacterial clearance in the peritoneal cavity and spleen was examined as an indicator of the innate immune response (Fig. 1) . In the peritoneal cavity (Fig. 1A) , in Control F1, the bacterial count decreased to 3:8 Â 10 1 AE 4:7 CFU/ml at 24 h and this level was maintained until 48 h. In contrast, in 15 ppm F1, 5:3 Â 10 3 AE 1:0 Â 10 3 CFU/ml remained in the peritoneal cavity until 48 h after infection. In 50 ppm F1, the bacterial number tended to remain higher than that in Control F1 at 24 h after infection, but at 48 h was similar to that in Control F1. In the spleen (Fig. 1B) , the bacterial number in Control F1 was 5:8 Â 10 2 AE 2:1 Â 10 2 CFU/ml at 24 h, with a similar level maintained until 48 h. In contrast, larger values were obtained for both TBTtreated groups, in particular in 15 ppm F1, at 24 h after infection. At 48 h after infection, the bacterial count in 50 ppm F1 was similar to that in Control F1, but in 15 ppm F1 it was higher than in the other groups, although no significant difference was observed.
Effect of TBT on the binding, phagocytosis, and killing of bacteria in neutrophils in vitro
To estimate the defensive responses of neutrophils Dams were given drinking water containing TBT (0, 15, or 50 ppm) from parturition to weaning. Offspring (n ¼ 8/group) exposed to TBT through breast milk from dams i.p. infected with E. coli K-12 (1 Â 10 8 CFU/mouse). The peritoneal exudates and spleen from offspring were obtained at 0, 6, 24, and 48 h after infection, and then viable bacteria at each time point were enumerated with TSA plates. Samples were tested three times to assess the repeatability and stability of the methods. Asterisks indicate a significant difference between the TBT-treated groups and the control group (p < 0:05). A, peritoneal cavity; B, spleen. from offspring exposed to TBT via lactation, the activities for the binding, phagocytosis, and killing of non-pathogenic bacteria were assayed in vitro (Fig. 2) . As shown in Fig. 2A, 1 .05% of all bacteria bound to the neutrophils from Control F1, whose activity was no different from that of neutrophils from 15 ppm F1. In contrast, 0.46% of bacteria bound to the neutrophils from 50 ppm F1, whose activity was significantly weaker than that of neutrophils from Control F1. Figure 2B shows the phagocytotic activity of the neutrophils. In Control F1, 0.06% of bound bacteria were phagocytized, whereas in 15 ppm F1 and 50 ppm F1, 0.024% and 0.015% respectively of bound bacteria were phagocytized. The phagocytosis of the TBTtreated groups was significantly reduced by the exposure. Figure 2C shows the killing activity of the neutrophils. At 20 min after incubation, the neutrophils from Control F1 and 50 ppm F1 showed similar killing activity, about 78% of all phagocytized bacteria, whereas only 50% of phagocytized bacteria were killed by the neutrophils from 15 ppm F1, whose activity had a tendency to decrease as compared with that from Control F1. At 60 min after incubation, the killing activity of the neutrophils from 50 ppm F1 was little changed, while that of the neutrophils from 15 ppm F1 was dramatically low.
Effect of TBT on the binding, phagocytosis, and killing of bacteria in macrophages in vitro Figure 3A shows the activity of macrophages from the offspring to bind E. coli K-12. The macrophages from Control F1 and 15 ppm F1 showed similar binding activity, whereas those from 50 ppm F1 had twice their activity. In phagocytotic activity (Fig. 3B) , compared with Control F1, the TBT-treated groups did not show a significant difference. The macrophages from 15 ppm F1 killed 10% of total phagocytized bacteria, while those from Control F1 and 50 ppm F1 killed about 40%, although the killing activity showed no significant differences between Control F1 and the TBT-treated groups (Fig. 3C) . Offspring exposed to TBT through breast milk were given an i.p. injection of casein. After 18 h, neutrophils (5 Â 10 5 cells/tube) from the peritoneal cavities were infected with E. coli K-12 (5 Â 10 7 CFU/tube) before incubation for 1 h at 4 C for binding. Further, the neutrophils were incubated at 37 C for 20 min to phagocytize bound bacteria. After that, the cells were incubated at 37 C for 20 min or 60 min to kill phagocytized bacteria. Samples were tested three times to assess the repeatability and stability of the methods. Asterisks indicate a significant difference between the TBT-treated group and the control group (p < 0:05). A, binding; B, phagocytotic; C, killing activities. Fig. 3 . Effects of TBT on the Binding, Phagocytotic, and Killing Activities of Macrophages from Offspring.
Offspring exposed to TBT through breast milk were given an i.p. injection with proteose peptone. After 42 h, macrophages were obtained from the peritoneal cavity. The macrophages (5 Â 10 5 cells/well) were infected with E. coli K-12 (5 Â 10 7 CFU/well) and incubated for 1 h at 4 C for binding. Further, the cells were incubated at 37 C for 30 min to phagocytize bound bacteria. After that, the cells were incubated at 37 C for 60 min to kill phagocytized bacteria. Samples were tested three times to assess the repeatability and stability of the methods. Asterisks indicate a significant difference between the TBT-treated groups and the control group (p < 0:05). A, binding; B, phagocytotic; C, killing activities.
Effect of TBT on the abilities of neutrophils and macrophages to produce cytokines and chemokines
No changes in IL-1, IL-6, or TNF-production from macrophages by TBT were observed between Control F1 and the TBT-treated offspring (data not shown), suggesting that TBT did not affect the production of these pro-inflammatory cytokines by macrophages. Figure 4 shows MCP-1 production of neutrophils obtained from Control F1 and the treated offspring. After challenge with E. coli K-12 in vitro, MCP-1 increased significantly in neutrophils obtained from 50 ppm F1, but not in those from 15 ppm F1.
TBT transfer to offspring via breast milk Because the level of TBT in breast milk in the subsequent exposure experiment was too low to detect with FPD, single shot administration using two high doses (1,000 mg/head or 3,000 mg/head) of TBT was performed to determine whether TBT was transferred to offspring via breast milk from dams. In the offspring breast-fed by dams given 1,000 mg/head and 3,000 mg/ head of TBT per mouse, TBT concentrations in stomach contents showed 0.21 mg/ml and 0.37 mg/ml respectively (Table 2 ). These results indicate that TBT transfers to offspring via breast milk, suggesting that the TBTtreated offspring were exposed to the compound via breast milk in the subsequent exposure experiment, in which, however, the level of TBT in breast milk was under the detection limit (50 ng/ml).
Discussion
In host defense against bacterial infection, innate immunity plays an important role in the early stages of infection by both non-pathogens and pathogens. 24, 25) In innate immunity, the bacteria at infectious foci are eliminated by neutrophils and macrophages. Under normal conditions, neutrophils migrate to infectious foci within 12 h in the first phase and resident macrophages migrate in the next phase. 26) Both play an important role in the elimination of bacteria via their binding, phagocytotic, and killing activities. In this study, to assess host defense in offspring exposed to TBT through lactation, offspring were i.p. infected with E. coli K-12 as a model of non-pathogenic bacterial infection, and bacterial clearance in the peritoneal cavity and spleen were examined. In addition, to clarify the mechanisms of the change in the ability of bacterial clearance, the anti-bacterial functions of neutrophils and macrophages were examined using an in vitro system. Our study shows that lactational exposure to TBT suppresses host defense against non-pathogenic bacteria in offspring due to a reduction in the killing activity of neutrophils.
In 15 ppm F1, we found that the bacterial clearance in the peritoneal cavity was significantly depressed in the infection experiment (Fig. 1) . This result indicates that exposure to TBT through lactation unfavorably affected the elimination of bacteria. In the peritoneal cavity, neutrophils play an important role in the clearance of bacteria at the early period of infection. From the experiment on the anti-bacterial functions of neutrophils, it was found that phagocytotic and killing activities were depressed (Fig. 2) . Previously, we found that exposure to Bisphenol-A depressed bacterial clearance in the peritoneal cavity and spleen to E. coli K-12, and that a reduction in the phagocytotic and killing activities of neutrophils resulted in the depression. 27) Therefore, in 15 ppm F1, it was conceivable that the reduced phagocytotic and killing activity of neutrophils was responsible for the decrease in bacterial clearance in the peritoneal cavity. On the other hand, the clearance in the spleen was not significantly different as between the treated and the control offspring. Since the activities of resident macrophages contribute to bacterial elimination in the spleen, 28) no significant effects on the phagocytotic and killing activities of macrophages (Fig. 3 ) appeared to be related to no significant changes in the clearance observed in the spleen. These results indicated that the lactational effect in 15 ppm F1 impaired the phagocytotic and killing activity of neutrophils, resulting in a decrease in the activity of bacterial clearance in the peritoneal cavity. 7 CFU/well) for 1 h. The cells were incubated in fresh RPMI 1640 medium containing 10% FCS for a further 5 h, and then centrifuged at 12,000 rpm for 5 min to collect a culture supernatant. MCP-1 in the supernatant was determined by sandwich ELISA. Samples were tested three times to assess the repeatability and stability of the methods. Asterisks indicate a significant difference between the TBT-treated groups and the control group (p < 0:05). In 50 ppm F1, the bacterial clearances in both the peritoneal cavity and spleen were not suppressed as compared to Control F1 (Fig. 1) . In terms of neutrophil function, the binding and phagocytotic activities were significantly reduced in 50 ppm F1 as compared to Control F1, but the killing activity was similar to that of the control (Fig. 2) . In terms of macrophage function, the binding activity was significantly higher than that of Control F1, but the phagocytotic and killing activity did not differ from Control F1 (Fig. 3) . These results also support the thesis that the killing activity of neutrophils is a major factor in bacterial clearance in the peritoneal cavity, as observed in 15 ppm F1.
Cytokines and chemokines regulate the anti-bacterial function of neutrophils and macrophages. 29) To clarify why it was that the clearance activity of the peritoneal cavity in 50 ppm F1 did not decrease, we examined the production of cytokines and chemokines related to antibacterial functions, such as MCP-1 production by neutrophils and IL-6, IL-1, and TNF-production by macrophages, after stimulation with E. coli K-12 in vitro. TNF-is an essential cytokine for macrophage activation 30) and activates resident macrophages. 31, 32) IL-6 and IL-1 are the main pro-inflammatory cytokines produced by macrophages, and IL-6 is an important mediator of acute-phase response after tissue damage or infection. 33) MCP-1, a chemokine produced by neutrophils, stimulates monocytes to migrate to infectious foci and to activate resident macrophages. [34] [35] [36] From the results of production of cytokines and a chemokine, MCP-1 was hyper-produced in 50 ppm F1 (Fig. 4) . Therefore the accumulation of macrophages induced by MCP-1 hyper-production might explain the result that the depression of bacterial clearance was less in 50 ppm F1 than in 15 ppm F1. Regarding the reason the killing activity of neutrophils did not decrease in 50 ppm F1, this calls for more study on the molecular level.
There are two factors in the effects of lactational exposure to TBT on offspring. One is the decrease in the body weight, and the other is the disruption of the innate immunodefense system. In addition, the single shot experiment (Table 2) indicated that TBT was transferred from mammary gland to milk. As the dose in consecutive administrations in this study was so much lower than those in the single shot, we speculate that the amount of TBT transferred to F1 during lactation was relative low. But TBT in breast milk appears to be an important factor in these effects.
In this study, a dose-dependent response was observed in the body weight (Table 1) , but not in the ability of bacterial clearance. Therefore, the no dose-dependent response suggests that the depression of innate immunodefenses is not related to the decrease in body weight. Such a no dose-dependency has been exhibited in many experiments using endocrine disruptors, including TBT. Tryphonas et al. 19) have also shown that the effects of TBT on the immune system in the F1 generation are not always dose-dependent.
In conclusion, we have shown that exposure to TBT during the lactation period alone suppressed host defense against non-pathogenic bacteria in offspring due to a reduction in the killing activity of neutrophils, although these results were not dose-dependent. Further studies might reveal the reason the positive effects were seen in 50 ppm F1, the higher group. The results of the present study are perhaps essential data in evaluating the risk assessment of TBT.
